TN2010000584A1 - Paediatric compositions for treating multiple scleoris - Google Patents

Paediatric compositions for treating multiple scleoris

Info

Publication number
TN2010000584A1
TN2010000584A1 TNP2010000584A TN2010000584A TN2010000584A1 TN 2010000584 A1 TN2010000584 A1 TN 2010000584A1 TN P2010000584 A TNP2010000584 A TN P2010000584A TN 2010000584 A TN2010000584 A TN 2010000584A TN 2010000584 A1 TN2010000584 A1 TN 2010000584A1
Authority
TN
Tunisia
Prior art keywords
scleoris
treating multiple
paediatric
compositions
paediatric compositions
Prior art date
Application number
TNP2010000584A
Other languages
French (fr)
Inventor
John Kovarik
Robert Schmouder
Marie-Claude Bastien
Olivier David
Goeril Karlsson
Thomas Bouillon
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/047885 external-priority patent/WO2009155475A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2010000584A1 publication Critical patent/TN2010000584A1/en

Links

Abstract

The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
TNP2010000584A 2009-06-19 2010-12-17 Paediatric compositions for treating multiple scleoris TN2010000584A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/047885 WO2009155475A1 (en) 2008-06-20 2009-06-19 Paediatric compositions for treating1 multiple sclerosis

Publications (1)

Publication Number Publication Date
TN2010000584A1 true TN2010000584A1 (en) 2012-05-24

Family

ID=55024660

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000584A TN2010000584A1 (en) 2009-06-19 2010-12-17 Paediatric compositions for treating multiple scleoris

Country Status (1)

Country Link
TN (1) TN2010000584A1 (en)

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
EA026667B9 (en) Pharmaceutical composition for treating hepatitis c virus
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
WO2013003629A3 (en) Methods and compositions for inhibition of bone resorption
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
UA109661C2 (en) Pharmaceutical compositions comprising co-crystals of tramadol and celecoxib
MX2013007336A (en) Bi-heteroaryl compounds as vps34 inhibitors.
WO2012021629A3 (en) Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
EA201490378A1 (en) TREATMENT OF MULTIPLE SCLEROSIS USING THE COMBINATION OF LACHINIMODA AND INTERFERON-β
WO2013100567A8 (en) Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2012046030A3 (en) Phosphodiesterase inhibitors
NZ616806A (en) Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
MX2009004017A (en) The uses of the carboxy-amido-triazole compounds and salts thereof.
MX2009012472A (en) Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis.
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
MX2015001917A (en) Pharmaceutical compositions of memantine.
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
WO2013062442A3 (en) Composition for the treatment of multiple sclerosis (variants)
WO2008031835A3 (en) Method of treating autoimmune diseases using vegf-pathway inhibitors
MX2009011819A (en) N-halogenated amino acid formulations.